New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
May 20, 2015
11:51 EDTAZNExpress Scripts' Medco to pay $7.9M to resolve kickback allegations
Medco Health Solutions, a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company (ESRX), of Missouri, has agreed to pay the government $7.9M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced. Medco provides pharmacy benefit management services to clients who receive subsidies under the Medicare Retiree Drug Subsidy program. The settlement resolves allegations that Medco solicited remuneration from AstraZeneca, a pharmaceutical manufacturer, in exchange for identifying Nexium as the “sole and exclusive” proton pump inhibitor on certain of Medco’s prescription drug lists known as formularies. The United States alleged that Medco received some or all of the remuneration from AstraZeneca in the form of reduced prices on the following AstraZeneca drugs: Prilosec, Toprol XL and Plendil. The United States contended that this kickback arrangement between Medco and AstraZeneca (AZN) violated the Federal Anti-Kickback statute, and thereby caused the submission of false or fraudulent claims for Nexium to the Retiree Drug Subsidy Program. In January 2015, the United States and AstraZeneca reached a $7.9M settlement to resolve kickback allegations arising out of the same conduct. This civil settlement resolves a lawsuit filed under the qui tam, or whistleblower, provision of the False Claims Act, which allows private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. The lawsuit was filed by former AstraZeneca employees Paul DiMattia and F. Folger Tuggle, whose share of the settlement has not been determined. The settlement with Medco was the result of a coordinated effort among the Civil Division, the U.S. Attorney’s Office of the District of Delaware and HHS-OIG.
11:39 EDTGEGE CEO Immelt confident Alstom deal will get approved
Subscribe for More Information
11:38 EDTGEGE CEO sees having a 'good' business in Oil&Gas
Targets reduction of approximately $1B in cumulative cost.
11:35 EDTGEGE CEO says company is in good shape financially
Subscribe for More Information
11:33 EDTGEGeneral Electric says Aviation will be better than prior view
11:31 EDTGEGE sees about $100B in finance asset sales in 2015 up from $90B
Subscribe for More Information
11:21 EDTGEGE capital portfolio execution ahead of plan
Subscribe for More Information
11:18 EDTGEGE on track for 2015 framework, sees solid organic growth and margin enhancement
Information from slides presentation prepared for 2015 Electrical Products Group Conference.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:46 EDTGSKDeutsche Bank positive on potential Pfizer, GSK merger
Deutsche Bank analyst Gregg Gilbert believes a large foreign deal for Pfizer (PFE) may make sense and says a buyout of GlaxoSmithKline (GSK) could be "materially" accretive to earnings while improving the company's tax situation over time. Gilbert assumes a $60 per share buyout price for GlaxoSmithKline in a research note this morning titled "Introducing 'PfizerKline'". The stock closed yesterday up 2c to $44.68. Gilbert reiterates a Buy rating on Pfizer with a $41 price target. Shares ended yesterday up 23c to $34.21.
07:14 EDTGEElectric Products Group to hold a conference
EPG 2015 is being held in Longboat Key, Florida on May 18-20 with webcasted company presentations to begin on May 20 at 7:30 am; not all company presentations may be webcasted. Webcast Link
06:25 EDTAAPLSamsung could release next Galaxy Note phone as early as July, BI reports
Subscribe for More Information
06:17 EDTGEGeneral Electric looking to sell Australia commercial lending unit, WSJ reports
Subscribe for More Information
06:08 EDTGEStocks with implied volatility below IV index mean; DD GE
Subscribe for More Information
May 19, 2015
18:54 EDTGEGE to lose $350M locomotives deal if Export-Import Bank fails, Reuters says
Subscribe for More Information
18:01 EDTGEAflac names Matthew Owenby as Chief Human Resources Officer
Subscribe for More Information
16:23 EDTAAPLOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
16:01 EDTAAPLOptions Update; May 19, 2015
iPath S&P 500 VIX Short-Term Futures down 27c to 19.17. Option volume leaders: AAPL BAC WMT MSFT FB TWTR MNKD NFLX T PBR
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
13:52 EDTAAPLPiper Jaffray says shelving television plans won't hurt Apple shares
Following a report by The Wall Street Journal that Apple (AAPL) shelved its television set plans "more than a year ago," Piper Jaffray issued a research note updating its view on the company. WHAT'S NEW: Prior to the market open, The Wall Street Journal released an article stating that, according to people familiar with the matter, Apple has "quietly shelved" its plans to develop a high-definition television set. The company experimented with video calls and 4K resolution as it searched for a justification to enter the TV market, but ultimately decided to instead focus on an online television service and a redesigned Apple TV device. Following the release of that article, Piper Jaffray analyst Gene Munster issued a note reconciling its long-held hope for an Apple television set with the Wall Street Journal's cancellation news. Later in the afternoon, Carl Icahn appeared on CNBC to respond to his recent open letter claiming that Apple was significantly undervalued, partly because of expectations for an Apple television set by 2016. In the CNBC interview, Icahn claimed the Wall Street Journal's article is contradictory, but maintained that the purpose of his letter was to spur additional stock repurchases by Apple. WHAT'S NOTABLE: Piper Jaffray said it believes there will be "no sustained impact" to Apple shares on the news because most analysts did not have definite expectations for a television. The firm believes that Apple will continue to develop its Apple TV set top box and possibly incorporate HomeKit, Siri, and an app store into the next model of the device. However, Piper did reiterate its belief that Apple will somehow move into the living room, citing statements by CEO Tim Cook calling the TV viewing experience "broken." The firm believes Apple is "actively" developing virtual and augmented reality products, though it cautions that a product launch could be five years away, if not more. Piper concluded with a reminder that its television expectations were not built into its model for Apple, and reiterated its Overweight rating and $162 price target. PRICE ACTION: Apple has advanced fractionally during the trading session, rising 0.35% to $130.65 at time of writing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use